PEPFAR receives additional funding in 2025? | Binary | | | 22 days ago | |
Will Lenacapavir reach 1 million people for HIV prevention by end of 2025? | Binary | | | 6 days ago | |
Which country will first approve Lenacapavir for HIV prevention by end of 2025? | Categorical | | | 6 days ago | |
Will FDA approve Lenacapavir for HIV prevention by mid-2025? | Binary | | | 6 days ago | |
What percentage of the 2 million target will be reached with Lenacapavir by end of 2025? | Categorical | | | 6 days ago | |
Will WHO recommend Lenacapavir for HIV prevention by end of 2025? | Binary | | | 6 days ago | |
What will be the primary funding source for Lenacapavir distribution by end of 2025? | Categorical | | | 6 days ago | |
Lenacapavir distribution to 2 million people completed by end of 2026? | Binary | | | 6 days ago | |
Lenacapavir maintains 100% success rate in real-world by end of 2025? | Binary | | | 6 days ago | |
Lenacapavir distribution delayed beyond early 2026? | Binary | | | 6 days ago | |
Region receiving largest share of Lenacapavir by end of 2025? | Categorical | | | 6 days ago | |
Primary barrier to Lenacapavir distribution by end of 2025? | Categorical | | | 6 days ago | |
Organization with highest Lenacapavir recipients by mid-2026? | Categorical | | | 6 days ago | |
UK achieves zero new HIV transmissions by 2030? | Binary | | | 22 days ago | |
UK expands HIV opt-out testing to 81 A&E departments by Dec 2025? | Binary | | | 22 days ago | |
Primary focus areas for UK HIV funding in 2025? | Categorical | | | 22 days ago | |
Country to lead in HIV/AIDS reduction by 2030? | Categorical | | | 22 days ago | |
Most significant barrier to HIV/AIDS elimination identified by WHO by end of 2025? | Categorical | | | 22 days ago | |
